Organization
Translational Research Institute and Dermatology Institute
4 abstracts
Abstract
SORBS1 expression as a biomarker for obesity and breast cancer prognosis: Insights from genomic analysis and survival outcomes.Org: Sidra Medicine, Shri Mata Vaishno Devi University, University of Kashmir, United Arab Emirates University, Translational Research Institute and Dermatology Institute,
Abstract
Genomic therapy matching in rare and refractory cancers: Updated results from a retrospective cohort study in the Molecular Screening and Therapeutic (MoST) program.Org: NHMRC Clinical Trials Centre, The University of Sydney, Garvan Institute of Medical Research, The NHMRC Clinical Trials Centre, Rare Cancer Laboratory,
Abstract
ARRY-162, A SELECTIVE, POTENT MEK1/2 INHIBITOR, SIGNIFICANTLY REDUCES EX VIVO IL-1 BETA AND TNF ALPHA; PRODUCTION IN NORMAL SUBJECTSOrg: Chemistry, Bar Ilan University, Ramat Gan, Israel, Biology Department, Bashkir State Medical University, Pharmacology Discovery Services Taiwan, Ltd., Translational Research Institute and Dermatology Institute, Drug Metabolism,
Abstract
ADALIMUMAB REDUCES CXCR4 EXPRESSION DURING INFLAMMATORY ARTHRITIS AND IN FIBROBLAST-LIKE SYNOVIOCYTES AND OSTEOCLASTS UNDER CHRONIC TNF EXPOSURE Org: Biologics & Biosimilars Collective Intelligence Consortium, Translational Research Institute and Dermatology Institute, Immunology Pharmacology, Abbvie Bioresearch Center, Worcester, United States,